|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM328917478 |
| 003 |
DE-627 |
| 005 |
20240725232724.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2021 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202102580
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1481.xml
|
| 035 |
|
|
|a (DE-627)NLM328917478
|
| 035 |
|
|
|a (NLM)34347325
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Li, Zhaoting
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy
|
| 264 |
|
1 |
|c 2021
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 24.07.2024
|
| 500 |
|
|
|a Date Revised 24.07.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2021 Wiley-VCH GmbH.
|
| 520 |
|
|
|a Bacteria are one of the main groups of organisms, which dynamically and closely participate in human health and disease development. With the integration of chemical biotechnology, bacteria have been utilized as an emerging delivery system for various biomedical applications. Given the unique features of bacteria such as their intrinsic biocompatibility and motility, bacteria-based delivery systems have drawn wide interest in the diagnosis and treatment of various diseases, including cancer, infectious diseases, kidney failure, and hyperammonemia. Notably, at the interface of chemical biotechnology and bacteria, many research opportunities have been initiated, opening a promising frontier in biomedical application. Herein, the current synergy of chemical biotechnology and bacteria, the design principles for bacteria-based delivery systems, the microbial modulation, and the clinical translation are reviewed, with a special focus on the emerging advances in diagnosis and therapy
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a bacteria
|
| 650 |
|
4 |
|a bioengineering
|
| 650 |
|
4 |
|a chemical engineering
|
| 650 |
|
4 |
|a diagnosis
|
| 650 |
|
4 |
|a therapy
|
| 700 |
1 |
|
|a Wang, Yixin
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Liu, Jun
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Rawding, Piper
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Bu, Jiyoon
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Hong, Seungpyo
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Hu, Quanyin
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 33(2021), 38 vom: 22. Sept., Seite e2102580
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:33
|g year:2021
|g number:38
|g day:22
|g month:09
|g pages:e2102580
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202102580
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 33
|j 2021
|e 38
|b 22
|c 09
|h e2102580
|